Detecting associations of rare variants with common diseases: collapsing or haplotyping?

检测罕见变异与常见疾病的关联:采用合并分析还是单倍型分析?

阅读:1

Abstract

In recent years, a myriad of new statistical methods have been proposed for detecting associations of rare single-nucleotide variants (SNVs) with common diseases. These methods can be generally classified as 'collapsing' or 'haplotyping' based. The former is the predominant class, composed of most of the rare variant association methods proposed to date. However, recent works have suggested that haplotyping-based methods may offer advantages and can even be more powerful than collapsing methods in certain situations. In this article, we review and compare collapsing- versus haplotyping-based methods/software in terms of both power and type I error. For collapsing methods, we consider three approaches: Combined Multivariate and Collapsing, Sequence Kernel Association Test and Family-Based Association Test (FBAT): the first two are population based and are among the most popular; the last test is family based, a modification from the popular FBAT to accommodate rare SNVs. For haplotyping-based methods, we include Logistic Bayesian Lasso (LBL) for population data and family-based LBL (famLBL) for family (trio) data. These two methods are selected, as they can be used to test association for specific rare and common haplotypes. Our results show that haplotype methods can be more powerful than collapsing methods if there are interacting SNVs leading to larger haplotype effects. Even if only common SNVs are genotyped, haplotype methods can still detect specific rare haplotypes that tag rare causal SNVs. As expected, family-based methods are robust, whereas population-based methods are susceptible, to population substructure. However, the population-based haplotype approach appears to have smaller inflation of type I error than its collapsing counterparts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。